These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10995035)

  • 21. Development of Noonan syndrome by deregulation of allosteric SOS autoactivation.
    Umutesi HG; Hoang HM; Johnson HE; Nam K; Heo J
    J Biol Chem; 2020 Sep; 295(39):13651-13663. PubMed ID: 32753483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Grb2 splice variant, Grb3-3, is a negative regulator of RAS activation.
    Seiler C; Stainthorp AK; Ketchen S; Jones CM; Marks K; Quirke P; Ladbury JE
    Commun Biol; 2022 Sep; 5(1):1029. PubMed ID: 36171279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coupled membrane lipid miscibility and phosphotyrosine-driven protein condensation phase transitions.
    Chung JK; Huang WYC; Carbone CB; Nocka LM; Parikh AN; Vale RD; Groves JT
    Biophys J; 2021 Apr; 120(7):1257-1265. PubMed ID: 33080222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. One-way membrane trafficking of SOS in receptor-triggered Ras activation.
    Christensen SM; Tu HL; Jun JE; Alvarez S; Triplet MG; Iwig JS; Yadav KK; Bar-Sagi D; Roose JP; Groves JT
    Nat Struct Mol Biol; 2016 Sep; 23(9):838-46. PubMed ID: 27501536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relating cellular signaling timescales to single-molecule kinetics: A first-passage time analysis of Ras activation by SOS.
    Huang WYC; Alvarez S; Kondo Y; Kuriyan J; Groves JT
    Proc Natl Acad Sci U S A; 2021 Nov; 118(45):. PubMed ID: 34740968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bimodality in Ras signaling originates from processivity of the Ras activator SOS without deterministic bistability.
    Lee AA; Kim NH; Alvarez S; Ren H; DeGrandchamp JB; Lew LJN; Groves JT
    Sci Adv; 2024 Jun; 10(25):eadi0707. PubMed ID: 38905351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autopromotion of K-Ras4B Feedback Activation Through an SOS-Mediated Long-Range Allosteric Effect.
    He X; Du K; Wang Y; Fan J; Li M; Ni D; Lu S; Bian X; Liu Y
    Front Mol Biosci; 2022; 9():860962. PubMed ID: 35463958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipid raft protein flotillin-1 is important for the interaction between SOS1 and H-Ras/K-Ras, leading to Ras activation.
    Jin H; Koh M; Lim H; Yong HY; Kim ES; Kim SY; Kim K; Jung J; Ryu WJ; Choi KY; Moon A
    Int J Cancer; 2023 May; 152(9):1933-1946. PubMed ID: 36691829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity.
    Maurer T; Garrenton LS; Oh A; Pitts K; Anderson DJ; Skelton NJ; Fauber BP; Pan B; Malek S; Stokoe D; Ludlam MJ; Bowman KK; Wu J; Giannetti AM; Starovasnik MA; Mellman I; Jackson PK; Rudolph J; Wang W; Fang G
    Proc Natl Acad Sci U S A; 2012 Apr; 109(14):5299-304. PubMed ID: 22431598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sequence analysis of the Ras-MAPK pathway genes SOS1, EGFR & GRB2 in silver foxes (Vulpes vulpes): candidate genes for hereditary hyperplastic gingivitis.
    Clark JA; Tully SJ; Dawn Marshall H
    Genetica; 2014 Dec; 142(6):517-23. PubMed ID: 25377643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allosteric autoactivation of SOS and its kinetic mechanism.
    Hoang HM; Umutesi HG; Heo J
    Small GTPases; 2021 Jan; 12(1):44-59. PubMed ID: 30983499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outlining the Grb2 interactome data and its interacting partners in HEK293 cells in absence and presence of epidermal growth factor.
    Duggal S; Midha MK; Kumar A; Rao KVS
    Data Brief; 2019 Aug; 25():104082. PubMed ID: 31245515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An overview of recent advancements in small molecules suppression of oncogenic signaling of K-RAS: an updated review.
    Sabt A; Tawfik HO; Khaleel EF; Badi RM; Ibrahim HAA; Elkaeed EB; Eldehna WM
    Mol Divers; 2024 Jan; ():. PubMed ID: 38289431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic anticancer effect of Grb2 and ITGA1 on cancer cells highly expressing Grb2 through suppressing ERK phosphorylation.
    Ma Q; Song J; Ma H; Gao K; Yang Y; He N
    Int J Clin Exp Pathol; 2019; 12(1):182-189. PubMed ID: 31933732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EGF Stimulates Rab35 Activation and Gastric Cancer Cell Migration by Regulating DENND1A-Grb2 Complex Formation.
    Ye B; Duan B; Deng W; Wang Y; Chen Y; Cui J; Sun S; Zhang Y; Du J; Gu L; Lin L; Tang Y
    Front Pharmacol; 2018; 9():1343. PubMed ID: 30524285
    [No Abstract]   [Full Text] [Related]  

  • 36. Regulation of ras exchange factors and cellular localization of ras activation by lipid messengers in T cells.
    Jun JE; Rubio I; Roose JP
    Front Immunol; 2013 Sep; 4():239. PubMed ID: 24027568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphic variants of H-RAS protooncogene and their possible role in bladder cancer etiology.
    Traczyk M; Borkowska E; Rożniecki M; Purpurowicz R; Jędrzejczyk A; Marks P; Pietrusiński M; Jabłonowski Z; Sosnowski M; Kałużewski B
    Cent European J Urol; 2012; 65(2):84-7. PubMed ID: 24578935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of small molecules that bind to K-Ras and inhibit Sos-mediated activation.
    Sun Q; Burke JP; Phan J; Burns MC; Olejniczak ET; Waterson AG; Lee T; Rossanese OW; Fesik SW
    Angew Chem Int Ed Engl; 2012 Jun; 51(25):6140-3. PubMed ID: 22566140
    [No Abstract]   [Full Text] [Related]  

  • 39. Therapeutic efficacy of liposomal Grb2 antisense oligodeoxynucleotide (L-Grb2) in preclinical models of ovarian and uterine cancer.
    Lara OD; Bayraktar E; Amero P; Ma S; Ivan C; Hu W; Wang Y; Mangala LS; Dutta P; Bhattacharya P; Ashizawa AT; Lopez-Berestein G; Rodriguez-Aguayo C; Sood AK
    Oncotarget; 2020 Jul; 11(29):2819-2833. PubMed ID: 32754300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Re: MicroRNA-449a acts as a tumor suppressor in human bladder cancer through the regulation of pocket proteins.
    Atala A
    J Urol; 2013 Jan; 189(1):385. PubMed ID: 23235255
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.